These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 38625517

  • 1. Adhesion and biofilm formation by two clinical isolates of Trichosporon Cutaneum in various environmental conditions.
    Piecuch A, Cal M, Ogórek R.
    Braz J Microbiol; 2024 Jun; 55(2):1793-1800. PubMed ID: 38625517
    [Abstract] [Full Text] [Related]

  • 2. Biofilm formation and antifungal susceptibility of Trichosporon asahii isolates from Mexican patients.
    Montoya AM, Elizondo-Zertuche M, Treviño-Rangel RJ, Becerril-García M, González GM.
    Rev Iberoam Micol; 2018 Jun; 35(1):22-26. PubMed ID: 29287630
    [Abstract] [Full Text] [Related]

  • 3. Multiple species of Trichosporon produce biofilms highly resistant to triazoles and amphotericin B.
    Iturrieta-González IA, Padovan AC, Bizerra FC, Hahn RC, Colombo AL.
    PLoS One; 2014 Jun; 9(10):e109553. PubMed ID: 25360765
    [Abstract] [Full Text] [Related]

  • 4. Farnesol inhibits planktonic cells and antifungal-tolerant biofilms of Trichosporon asahii and Trichosporon inkin.
    Cordeiro RA, Pereira LMG, de Sousa JK, Serpa R, Andrade ARC, Portela FVM, Evangelista AJJ, Sales JA, Aguiar ALR, Mendes PBL, Brilhante RSN, Sidrim JJDC, Castelo-Branco DSCM, Rocha MFG.
    Med Mycol; 2019 Nov 01; 57(8):1038-1045. PubMed ID: 30649480
    [Abstract] [Full Text] [Related]

  • 5. Susceptibilities to amphotericin B, fluconazole and voriconazole of Trichosporon clinical isolates.
    Tsai MS, Yang YL, Wang AH, Wang LS, Lu DC, Liou CH, Hsieh LY, Wu CJ, Cheng MF, Shi ZY, Lo HJ.
    Mycopathologia; 2012 Aug 01; 174(2):121-30. PubMed ID: 22318636
    [Abstract] [Full Text] [Related]

  • 6. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.
    Sun W, Su J, Xu S, Yan D.
    J Med Microbiol; 2012 Dec 01; 61(Pt 12):1750-1757. PubMed ID: 22956749
    [Abstract] [Full Text] [Related]

  • 7. Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance.
    Di Bonaventura G, Pompilio A, Picciani C, Iezzi M, D'Antonio D, Piccolomini R.
    Antimicrob Agents Chemother; 2006 Oct 01; 50(10):3269-76. PubMed ID: 17005804
    [Abstract] [Full Text] [Related]

  • 8. Aspects related to biofilm production and antifungal susceptibility of clinically relevant yeasts of the genus Trichosporon.
    Lara BR, de Camargo BB, Paula CR, Monari GPM, Garces HG, Arnoni MV, Silveira M, Gimenes VMF, Leite Junior DP, Bonfietti LX, Oliveira L, Melhem MSC, Auler M, Ramos RTB, Dias ALT, Silva NC, Moreira D, Richini-Pereira VB, Anversa L, Ruiz LDS.
    Med Mycol; 2023 Mar 02; 61(3):. PubMed ID: 36807459
    [Abstract] [Full Text] [Related]

  • 9. Isolation and antifungal susceptibility testing of Trichosporon asahii in Ceará, Brazil.
    Menezes EA, Marinho JA, Angelo MR, Cunha Mda C, Cunha FA, Vasconcelos Júnior AA.
    Rev Inst Med Trop Sao Paulo; 2012 Mar 02; 54(1):1-3. PubMed ID: 22370746
    [Abstract] [Full Text] [Related]

  • 10. Molecular Identification, Genotyping, Phenotyping, and Antifungal Susceptibilities of Medically Important Trichosporon, Apiotrichum, and Cutaneotrichosporon Species.
    do Espírito Santo EPT, Monteiro RC, da Costa ARF, Marques-da-Silva SH.
    Mycopathologia; 2020 Apr 02; 185(2):307-317. PubMed ID: 31776790
    [Abstract] [Full Text] [Related]

  • 11. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
    Mariné M, Bom VL, de Castro PA, Winkelstroter LK, Ramalho LN, Brown NA, Goldman GH.
    Virulence; 2015 Apr 02; 6(5):476-86. PubMed ID: 25751127
    [Abstract] [Full Text] [Related]

  • 12. Effect of resveratrol and Regrapex-R-forte on Trichosporon cutaneum biofilm.
    Paldrychová M, Kolouchová I, Vaňková E, Maťátková O, Šmidrkal J, Krmela A, Schulzová V, Hajšlová J, Masák J.
    Folia Microbiol (Praha); 2019 Jan 02; 64(1):73-81. PubMed ID: 30062620
    [Abstract] [Full Text] [Related]

  • 13. Genotyping, antifungal susceptibility testing, and biofilm formation of Trichosporon spp. isolated from urine samples in a University Hospital in Bangkok, Thailand.
    Wongsuk T, Boonsilp S, Pumeesat P, Homkaew A, Sangsri T, Chongtrakool P.
    Acta Microbiol Immunol Hung; 2022 Sep 16; 69(3):247-257. PubMed ID: 35976734
    [Abstract] [Full Text] [Related]

  • 14. Genotype, antifungal susceptibility, and biofilm formation of Trichosporon asahii isolated from the urine of hospitalized patients.
    Almeida AA, Crispim Bdo A, Grisolia AB, Svidzinski TI, Ortolani LG, Oliveira KM.
    Rev Argent Microbiol; 2016 Sep 16; 48(1):62-6. PubMed ID: 26916812
    [Abstract] [Full Text] [Related]

  • 15. Epidemiology and Antifungal Susceptibility of Infections Caused by Trichosporon Species: An Emerging Non-Candida and Non-Cryptococcus Yeast Worldwide.
    Singh S, Capoor MR, Varshney S, Gupta DK, Verma PK, Ramesh V.
    Indian J Med Microbiol; 2019 Sep 16; 37(4):536-541. PubMed ID: 32436877
    [Abstract] [Full Text] [Related]

  • 16. Taxonomic position of deep-seated, mucosa-associated, and superficial isolates of Trichosporon cutaneum from trichosporonosis patients.
    Sugita T, Nishikawa A, Shinoda T, Kume H.
    J Clin Microbiol; 1995 May 16; 33(5):1368-70. PubMed ID: 7615757
    [Abstract] [Full Text] [Related]

  • 17. Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres.
    Francisco EC, de Almeida Junior JN, de Queiroz Telles F, Aquino VR, Mendes AVA, de Andrade Barberino MGM, de Tarso O Castro P, Guimarães T, Hahn RC, Padovan ACB, Chaves GM, Colombo AL.
    Clin Microbiol Infect; 2019 Jul 16; 25(7):909.e1-909.e5. PubMed ID: 30991116
    [Abstract] [Full Text] [Related]

  • 18. Hospital Trichosporon asahii isolates with simple architecture biofilms and high resistance to antifungals routinely used in clinical practice.
    Malacrida AM, Corrêa JL, Barros ILE, Veiga FF, Pereira EDCA, Negri M, Svidzinski TIE.
    J Mycol Med; 2023 May 16; 33(2):101356. PubMed ID: 36563454
    [Abstract] [Full Text] [Related]

  • 19. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan.
    Ruan SY, Chien JY, Hsueh PR.
    Clin Infect Dis; 2009 Jul 01; 49(1):e11-7. PubMed ID: 19489711
    [Abstract] [Full Text] [Related]

  • 20. Genotyping and antifungal drug susceptibility of Trichosporon asahii isolated from Chinese patients.
    Xia Z, Yang R, Wang W, Cong L.
    Mycopathologia; 2012 Mar 01; 173(2-3):127-33. PubMed ID: 21979867
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.